This inventor holds 3 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Dupont Nutrition Biosciences Aps, Proteonic Biotechnology IP Bv, Other. Active years: 2020-2023.
Location History:
- Voorschoten, NL (2020)
- ZN Voorschoten, NL (2023)
Company Filing History:
1 out of 149 
1 out of 4 
1 out of 834,350 Years Active: 2020-2023
Title: Innovations of Sharief Barends in Synthetic Xylanases
Introduction
Sharief Barends is an inventor based in the Netherlands, known for his contributions to the field of biotechnology. His work primarily focuses on the development of novel synthetic xylanases, which are enzymes that play a crucial role in the breakdown of xylan, a major component of plant cell walls.
Latest Patents
Sharief Barends holds a patent for his invention titled "Novel Synthetic Xylanases." This invention relates to an isolated polypeptide having xylanase activity. The polypeptide is selected from a specific group, which includes: a polypeptide comprising an amino acid sequence with at least 87% identity with SEQ ID NO: 1; a polypeptide encoded by a polynucleotide with at least 87% identity with SEQ ID NO: 2; or a fragment of a polypeptide that retains xylanase activity. Despite his innovative work, he currently has 3 patents registered.
Career Highlights
Throughout his career, Sharief Barends has focused on advancing the understanding and application of xylanases in various industries. His research has implications for biofuel production, paper manufacturing, and food processing, showcasing the versatility of his inventions.
Collaborations
Sharief has collaborated with Rikke Hoeegh Lorentsen, contributing to the development of his patented technology. Their partnership highlights the importance of teamwork in scientific research and innovation.
Conclusion
Sharief Barends is a notable inventor in the field of synthetic xylanases, with a focus on creating innovative solutions for various applications. His work continues to pave the way for advancements in biotechnology.